Pet antibiotics are medications prescribed by veterinarians to treat bacterial infections in various types of pets, including dogs, cats, and other animals. These antibiotics are similar to those used in humans but are specifically formulated and dosed for animals. Just like humans, pets can develop bacterial infections that can lead to various health issues if left untreated. Pet antibiotics help combat these infections and promote the well-being of the animals.
The global Pet Antibiotic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 496%.
This report aims to provide a comprehensive presentation of the global market for Pet Antibiotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Antibiotic.
Report Scope
The Pet Antibiotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Antibiotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Antibiotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco
Zoetis
Merck Animal Health
Merial
Bayer HealthCare
Boehringer Ingelheim GmbH
Ceva Sant茅 Animale
Virbac Group
HealthforAnimals
Cymedica
Dechra
Jinhe Biotechnology
Orion Corporation
Phibro Animal Health Corporation
Vetoquinol
Virbac
Zydus
Segment by Type
Oral
Injection
Others
Segment by Application
Dogs
Cats
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Antibiotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Pet Antibiotic Market Overview
1.1 Product Overview and Scope of Pet Antibiotic
1.2 Pet Antibiotic Segment by Type
1.2.1 Global Pet Antibiotic Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Pet Antibiotic Segment by Application
1.3.1 Global Pet Antibiotic Market Value by Application: (2024-2030)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Others
1.4 Global Pet Antibiotic Market Size Estimates and Forecasts
1.4.1 Global Pet Antibiotic Revenue 2019-2030
1.4.2 Global Pet Antibiotic Sales 2019-2030
1.4.3 Global Pet Antibiotic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Antibiotic Market Competition by Manufacturers
2.1 Global Pet Antibiotic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Antibiotic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Antibiotic Average Price by Manufacturers (2019-2024)
2.4 Global Pet Antibiotic Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Antibiotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Antibiotic, Product Type & Application
2.7 Pet Antibiotic Market Competitive Situation and Trends
2.7.1 Pet Antibiotic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Antibiotic Players Market Share by Revenue
2.7.3 Global Pet Antibiotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Antibiotic Retrospective Market Scenario by Region
3.1 Global Pet Antibiotic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Antibiotic Global Pet Antibiotic Sales by Region: 2019-2030
3.2.1 Global Pet Antibiotic Sales by Region: 2019-2024
3.2.2 Global Pet Antibiotic Sales by Region: 2025-2030
3.3 Global Pet Antibiotic Global Pet Antibiotic Revenue by Region: 2019-2030
3.3.1 Global Pet Antibiotic Revenue by Region: 2019-2024
3.3.2 Global Pet Antibiotic Revenue by Region: 2025-2030
3.4 North America Pet Antibiotic Market Facts & Figures by Country
3.4.1 North America Pet Antibiotic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Antibiotic Sales by Country (2019-2030)
3.4.3 North America Pet Antibiotic Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet Antibiotic Market Facts & Figures by Country
3.5.1 Europe Pet Antibiotic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Antibiotic Sales by Country (2019-2030)
3.5.3 Europe Pet Antibiotic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Antibiotic Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Antibiotic Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Antibiotic Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Antibiotic Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pet Antibiotic Market Facts & Figures by Country
3.7.1 Latin America Pet Antibiotic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Antibiotic Sales by Country (2019-2030)
3.7.3 Latin America Pet Antibiotic Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Antibiotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Antibiotic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Antibiotic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Antibiotic Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Antibiotic Sales by Type (2019-2030)
4.1.1 Global Pet Antibiotic Sales by Type (2019-2024)
4.1.2 Global Pet Antibiotic Sales by Type (2025-2030)
4.1.3 Global Pet Antibiotic Sales Market Share by Type (2019-2030)
4.2 Global Pet Antibiotic Revenue by Type (2019-2030)
4.2.1 Global Pet Antibiotic Revenue by Type (2019-2024)
4.2.2 Global Pet Antibiotic Revenue by Type (2025-2030)
4.2.3 Global Pet Antibiotic Revenue Market Share by Type (2019-2030)
4.3 Global Pet Antibiotic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Antibiotic Sales by Application (2019-2030)
5.1.1 Global Pet Antibiotic Sales by Application (2019-2024)
5.1.2 Global Pet Antibiotic Sales by Application (2025-2030)
5.1.3 Global Pet Antibiotic Sales Market Share by Application (2019-2030)
5.2 Global Pet Antibiotic Revenue by Application (2019-2030)
5.2.1 Global Pet Antibiotic Revenue by Application (2019-2024)
5.2.2 Global Pet Antibiotic Revenue by Application (2025-2030)
5.2.3 Global Pet Antibiotic Revenue Market Share by Application (2019-2030)
5.3 Global Pet Antibiotic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Elanco
6.1.1 Elanco Corporation Information
6.1.2 Elanco Description and Business Overview
6.1.3 Elanco Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Elanco Pet Antibiotic Product Portfolio
6.1.5 Elanco Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Pet Antibiotic Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Corporation Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Animal Health Pet Antibiotic Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Merial
6.4.1 Merial Corporation Information
6.4.2 Merial Description and Business Overview
6.4.3 Merial Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merial Pet Antibiotic Product Portfolio
6.4.5 Merial Recent Developments/Updates
6.5 Bayer HealthCare
6.5.1 Bayer HealthCare Corporation Information
6.5.2 Bayer HealthCare Description and Business Overview
6.5.3 Bayer HealthCare Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer HealthCare Pet Antibiotic Product Portfolio
6.5.5 Bayer HealthCare Recent Developments/Updates
6.6 Boehringer Ingelheim GmbH
6.6.1 Boehringer Ingelheim GmbH Corporation Information
6.6.2 Boehringer Ingelheim GmbH Description and Business Overview
6.6.3 Boehringer Ingelheim GmbH Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim GmbH Pet Antibiotic Product Portfolio
6.6.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.7 Ceva Sant茅 Animale
6.6.1 Ceva Sant茅 Animale Corporation Information
6.6.2 Ceva Sant茅 Animale Description and Business Overview
6.6.3 Ceva Sant茅 Animale Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Sant茅 Animale Pet Antibiotic Product Portfolio
6.7.5 Ceva Sant茅 Animale Recent Developments/Updates
6.8 Virbac Group
6.8.1 Virbac Group Corporation Information
6.8.2 Virbac Group Description and Business Overview
6.8.3 Virbac Group Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Virbac Group Pet Antibiotic Product Portfolio
6.8.5 Virbac Group Recent Developments/Updates
6.9 HealthforAnimals
6.9.1 HealthforAnimals Corporation Information
6.9.2 HealthforAnimals Description and Business Overview
6.9.3 HealthforAnimals Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.9.4 HealthforAnimals Pet Antibiotic Product Portfolio
6.9.5 HealthforAnimals Recent Developments/Updates
6.10 Cymedica
6.10.1 Cymedica Corporation Information
6.10.2 Cymedica Description and Business Overview
6.10.3 Cymedica Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cymedica Pet Antibiotic Product Portfolio
6.10.5 Cymedica Recent Developments/Updates
6.11 Dechra
6.11.1 Dechra Corporation Information
6.11.2 Dechra Pet Antibiotic Description and Business Overview
6.11.3 Dechra Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dechra Pet Antibiotic Product Portfolio
6.11.5 Dechra Recent Developments/Updates
6.12 Jinhe Biotechnology
6.12.1 Jinhe Biotechnology Corporation Information
6.12.2 Jinhe Biotechnology Pet Antibiotic Description and Business Overview
6.12.3 Jinhe Biotechnology Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jinhe Biotechnology Pet Antibiotic Product Portfolio
6.12.5 Jinhe Biotechnology Recent Developments/Updates
6.13 Orion Corporation
6.13.1 Orion Corporation Corporation Information
6.13.2 Orion Corporation Pet Antibiotic Description and Business Overview
6.13.3 Orion Corporation Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Orion Corporation Pet Antibiotic Product Portfolio
6.13.5 Orion Corporation Recent Developments/Updates
6.14 Phibro Animal Health Corporation
6.14.1 Phibro Animal Health Corporation Corporation Information
6.14.2 Phibro Animal Health Corporation Pet Antibiotic Description and Business Overview
6.14.3 Phibro Animal Health Corporation Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Phibro Animal Health Corporation Pet Antibiotic Product Portfolio
6.14.5 Phibro Animal Health Corporation Recent Developments/Updates
6.15 Vetoquinol
6.15.1 Vetoquinol Corporation Information
6.15.2 Vetoquinol Pet Antibiotic Description and Business Overview
6.15.3 Vetoquinol Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Vetoquinol Pet Antibiotic Product Portfolio
6.15.5 Vetoquinol Recent Developments/Updates
6.16 Virbac
6.16.1 Virbac Corporation Information
6.16.2 Virbac Pet Antibiotic Description and Business Overview
6.16.3 Virbac Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Virbac Pet Antibiotic Product Portfolio
6.16.5 Virbac Recent Developments/Updates
6.17 Zydus
6.17.1 Zydus Corporation Information
6.17.2 Zydus Pet Antibiotic Description and Business Overview
6.17.3 Zydus Pet Antibiotic Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zydus Pet Antibiotic Product Portfolio
6.17.5 Zydus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Antibiotic Industry Chain Analysis
7.2 Pet Antibiotic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Antibiotic Production Mode & Process
7.4 Pet Antibiotic Sales and Marketing
7.4.1 Pet Antibiotic Sales Channels
7.4.2 Pet Antibiotic Distributors
7.5 Pet Antibiotic Customers
8 Pet Antibiotic Market Dynamics
8.1 Pet Antibiotic Industry Trends
8.2 Pet Antibiotic Market Drivers
8.3 Pet Antibiotic Market Challenges
8.4 Pet Antibiotic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Elanco
Zoetis
Merck Animal Health
Merial
Bayer HealthCare
Boehringer Ingelheim GmbH
Ceva Sant茅 Animale
Virbac Group
HealthforAnimals
Cymedica
Dechra
Jinhe Biotechnology
Orion Corporation
Phibro Animal Health Corporation
Vetoquinol
Virbac
Zydus
听
听
*If Applicable.